These differences were highly significant and reflect a ≥ 99.9% reduction in parasite burden in the K11777 treated group.
← all excerpts
Two key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis.
1
—
—